{"title": [{"text": "UWM-TRIADS: Classifying Drug-Drug Interactions with Two-Stage SVM and Post-Processing", "labels": [], "entities": [{"text": "UWM-TRIADS", "start_pos": 0, "end_pos": 10, "type": "DATASET", "confidence": 0.8603674173355103}, {"text": "Classifying Drug-Drug Interactions", "start_pos": 12, "end_pos": 46, "type": "TASK", "confidence": 0.8462515076001486}]}], "abstractContent": [{"text": "We describe our system for the DDIExtraction-2013 shared task of classifying Drug-Drug interactions (DDIs) given labeled drug mentions.", "labels": [], "entities": [{"text": "classifying Drug-Drug interactions (DDIs) given labeled drug mentions", "start_pos": 65, "end_pos": 134, "type": "TASK", "confidence": 0.8095815479755402}]}, {"text": "The challenge called fora five-way classification of all drug pairs in each sentence: a drug pair is either non-interacting, or interacting as one of four types.", "labels": [], "entities": []}, {"text": "Our approach begins with the use of a two-stage weighted SVM classifier to handle the highly unbalanced class distribution: the first stage fora binary classification of drug pairs as interacting or non-interacting, and the second stage for further classification of interacting pairs from the first stage into one of the four interacting types.", "labels": [], "entities": []}, {"text": "Our SVM features exploit stemmed words, lemmas, bigrams, part of speech tags, verb lists, and similarity measures, among others.", "labels": [], "entities": []}, {"text": "For each stage, we also developed a set of post-processing rules based on observations in the training data.", "labels": [], "entities": []}, {"text": "Our best system achieved 0.472 F-measure.", "labels": [], "entities": [{"text": "F-measure", "start_pos": 31, "end_pos": 40, "type": "METRIC", "confidence": 0.9976372718811035}]}], "introductionContent": [{"text": "Potential drug-drug interactions (DDIs), defined as the co-prescription of two drugs that are known to interact, area significant source of preventable drug-related harm (i.e., adverse drug events, or ADEs) ().", "labels": [], "entities": [{"text": "Potential drug-drug interactions (DDIs)", "start_pos": 0, "end_pos": 39, "type": "TASK", "confidence": 0.7309975226720175}]}, {"text": "Gurwitz et al, in their cohort study of ADEs among older Americans receiving ambulatory care, found that 13.3% of preventable errors leading to an ADE involved the co-prescription of drugs for which a \"...well established, clinically important interaction\" was known (.", "labels": [], "entities": []}, {"text": "Nearly 7% (23/338) of the ADEs experienced by residents of two academic nursing homes over a nine-month period were attributable to DDIs).", "labels": [], "entities": []}, {"text": "Sixteen cohort and casecontrol studies reported an elevated risk of hospitalization in patients who were exposed to).", "labels": [], "entities": []}, {"text": "Failure to properly manage a DDI is a medical error, and the Institute of Medicine has noted that alack of drug knowledge is one of the most frequent proximal causes of such errors (Committee on.", "labels": [], "entities": []}, {"text": "Indeed, healthcare providers often have inadequate knowledge of what drug interactions can occur, of patient specific factors that can increase the risk of harm from an interaction, and how to properly manage an interaction when patient exposure cannot be avoided).", "labels": [], "entities": []}, {"text": "Unfortunately, there is no single complete and authoritative source of DDI knowledge.", "labels": [], "entities": []}, {"text": "Rather, there are multiple sources, each tasked with extracting, evaluating, and staying up-to-date with pertinent DDIs reported in the literature, and drug product labeling ( ).", "labels": [], "entities": [{"text": "drug product labeling", "start_pos": 152, "end_pos": 173, "type": "TASK", "confidence": 0.6730048259099325}]}, {"text": "The dynamic nature of drug knowledge, combined with the enormity of the biomedical literature, makes this task extremely challenging.", "labels": [], "entities": []}, {"text": "Hence, natural language processing methods for identifying and extracting DDIs are receiving increased attention.", "labels": [], "entities": [{"text": "identifying and extracting DDIs", "start_pos": 47, "end_pos": 78, "type": "TASK", "confidence": 0.6905209571123123}]}, {"text": "In 2011, the first shared task challenge for DDI extraction,, invited participants to develop automatic methods to extract DDIs.", "labels": [], "entities": [{"text": "DDI extraction", "start_pos": 45, "end_pos": 59, "type": "TASK", "confidence": 0.8735848069190979}]}, {"text": "The task focused on the identification of all possible pairs of interacting drugs, without specifying anything further about the interactions.", "labels": [], "entities": []}, {"text": "By contrast, the shared task emphasized the importance of recognizing what is being asserted about the interaction.", "labels": [], "entities": []}, {"text": "Accordingly, the challenge called fora five-way classification of sentences for each drug-pair: \u2022 Advice: the sentence notes a recommendation or advice related to the concomitant use of the two drugs (e.g., \"\u2026 UROXATRAL should NOT be used in combination with other alpha-blockers.\"); \u2022 Effect: the sentence states the effect of the drug interaction, including pharmacodynamic effect or mechanism of interaction (e.g., \"Quinolones may enhance the effects of the oral anticoagulant, warfarin, \u2026\"); \u2022 Mechanism: the sentence describes a pharmacokinetic mechanism (e.g., \"Grepafloxacin is a competitive inhibitor of the metabolism of theophylline.\").", "labels": [], "entities": [{"text": "UROXATRAL", "start_pos": 210, "end_pos": 219, "type": "METRIC", "confidence": 0.9917694330215454}]}, {"text": "\u2022 Int: the sentence mentions a drug interaction but doesn't provide any additional information (e.g., \"The interaction of omeprazole and ketoconazole has been established.\").", "labels": [], "entities": [{"text": "Int", "start_pos": 2, "end_pos": 5, "type": "METRIC", "confidence": 0.9922212958335876}]}, {"text": "\u2022 None: the sentence does not show an interaction between the two drugs; To focus on, and separately evaluate, different aspects of the problem, the 2013 shared task was divided into two subtasks.", "labels": [], "entities": []}, {"text": "One task focused on the recognition and classification of drug names, while the other focused on the identification and classification of DDIs, with the drug names provided from the gold standard.", "labels": [], "entities": [{"text": "recognition and classification of drug names", "start_pos": 24, "end_pos": 68, "type": "TASK", "confidence": 0.876204639673233}, {"text": "identification and classification of DDIs", "start_pos": 101, "end_pos": 142, "type": "TASK", "confidence": 0.8285660862922668}]}, {"text": "In this paper, we describe our approach for handling the second task, namely, DDI identification and classification of all possible pairs of drugs in the provided corpus.", "labels": [], "entities": [{"text": "DDI identification", "start_pos": 78, "end_pos": 96, "type": "TASK", "confidence": 0.9547788500785828}]}, {"text": "Our approach combined machinelearning methods with the use of rules for postprocessing.", "labels": [], "entities": []}, {"text": "A key feature of our machinelearning approach is that it is specifically designed to handle the highly unbalanced class distribution via the use of a two-stage weighted SVM classifier.", "labels": [], "entities": []}, {"text": "In addition to a variety of features exploited for the classifier, we also developed a set of post-processing rules, with a different set of rules applied after each stage of SVM classification.", "labels": [], "entities": [{"text": "SVM classification", "start_pos": 175, "end_pos": 193, "type": "TASK", "confidence": 0.9122350811958313}]}, {"text": "Finally, our approach is also aimed towards exploring the efficacy of methods that do not need to rely on syntactic-parse based features.", "labels": [], "entities": []}, {"text": "The paper is organized as follows.", "labels": [], "entities": []}, {"text": "In the next section, we describe the training and test data set used in the challenge.", "labels": [], "entities": []}, {"text": "In section 3, we describe our method, the classifiers used at each stage, their features, and post processing.", "labels": [], "entities": []}, {"text": "In section 4, we present the evaluation and results.", "labels": [], "entities": []}, {"text": "We conclude in Section 5 with discussion and future work.", "labels": [], "entities": []}], "datasetContent": [], "tableCaptions": [{"text": " Table 3: Class weight assignments in different systems", "labels": [], "entities": [{"text": "Class weight assignments", "start_pos": 10, "end_pos": 34, "type": "TASK", "confidence": 0.6606832245985667}]}, {"text": " Table 2. Results of each system. The three systems are  described in Section 3.4.3.", "labels": [], "entities": []}]}